Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
150.40    -2.20 (-1.44%)
Bid:
150.90
Ask:
151.10
Spread: 0.20 (0.133%)
Market Cap: £1.11b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Offer Update

6 Aug 2010 12:49

RNS Number : 6870Q
Sovereign Reversions PLC
06 August 2010
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE to do so would constitute a violation of the relevant laws of that jurisdiction.

 

RECOMMENDED ACQUISITION

of

 

Sovereign Reversions plc

by

Grainger Equity Release Limited

(a wholly owned subsidiary of Grainger plc)

 

to be effected

by means of a Scheme of Arrangement

under Part 26 of the Companies Act 2006

 

Court Order Confirming the Reduction of Capital

 

For immediate release

6 August 2010

 

Sovereign Reversions plc ("Sovereign") is pleased to announce that the Court has today confirmed the reduction of Sovereign's share capital in connection with the Scheme by which the recommended acquisition of Sovereign by Grainger Equity Release Limitedis being implemented. This follows the Court's sanctioning of the Scheme at a hearing held on 4 August 2010.

 

The Scheme will become effective upon the Court Order confirming the reduction of capital being delivered to and, as ordered by the Court, registered with the Registrar of Companies, which is expected to take place on 9 August 2010.

 

Trading in Sovereign Shares on AIM was suspended with effect from 5.00 p.m. on 5 August 2010. It is expected that the admission of the Shares to trading on AIM will be cancelled with effect from 8.00 a.m. on 10 August 2010.

 

Despatch of cheques or settlement through CREST (as appropriate) in respect of the consideration will take place no later than 24 August 2010.

 

For further information please contact:

 

Grainger plc

Tel: 020 7795 4700

Andrew Cunningham, Chief Executive

Peter Couch, Chief Operating Officer

Dave Butler, Director, Corporate Affairs

J.P. Morgan Cazenove, Financial Adviser to Grainger

Tel: 020 7588 2828

Robert Fowlds

Bronson Albery

Financial Dynamics, Financial PR to Grainger

Tel: 020 7831 3113

Stephanie Highett

Dido Laurimore

Rachel Drysdale

Sovereign Reversions plc

Tel: 01234 356300

Graeme Marshall, Chief Executive

Rupert Pearce Gould, Executive Director

Charles Stanley Securities, Joint Rule 3 Adviser and broker to Sovereign Reversions

Tel: 020 7149 6000

Dugald Carlean

Ben Johnston

Fairfax I.S. PLC, Joint Rule 3 Adviser to Sovereign Reversions

Tel: 020 7598 5368

David Floyd

Andrew Cox

Wriglesworth Consultancy, Financial PR to Sovereign Reversions

Mark Baker

Tel: 07980 635 243

Tom Urpeth

Tel: 020 7427 1400

 

Charles Stanley Securities, a division of Charles Stanley & Co Limited is acting exclusively for Sovereign Reversions and no one else in connection with the possible Transaction and will not be responsible to anyone other than Sovereign Reversions for providing the protections afforded to customers of Charles Stanley Securities or for providing advice in relation to the possible Transaction or any other matter referred to herein.

 

Fairfax I.S. PLC is acting exclusively for Sovereign Reversions and no one else in connection with the possible Transaction and will not be responsible to anyone other than Sovereign Reversions for providing the protections afforded to customers of Fairfax I.S. PLC or for providing advice in relation to the possible Transaction or any other matter referred to herein.

 

J.P. Morgan Cazenove is a marketing name for the UK investment banking business of J.P. Morgan plc and its associated companies. J.P. Morgan Cazenove is acting exclusively for Grainger and no one else in connection with the possible Transaction and will not be responsible to anyone other than Grainger for providing the protections afforded to customers of J.P. Morgan Cazenove or for providing advice in relation to the possible Transaction or any other matter referred to herein.

Dealing disclosure requirements

 

Under Rule 8.3(a) of the City Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (UK time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (UK time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the City Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (UK time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal of informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPKKADQDBKDAFK
Date   Source Headline
7th Mar 202312:46 pmRNSDirector/PDMR Shareholding
15th Feb 20231:35 pmRNSDirector/PDMR Shareholding
8th Feb 20234:16 pmRNSResult of AGM
8th Feb 20237:00 amRNSTrading Update
7th Feb 202312:12 pmRNSDirector/PDMR Shareholding
7th Feb 202312:08 pmRNSDirector/PDMR Shareholding
6th Feb 20233:14 pmRNSTotal Voting Rights
20th Jan 20235:12 pmRNSAGM Statement
12th Jan 202312:16 pmRNSTotal Voting Rights
10th Jan 20232:33 pmRNSDirector/PDMR Shareholding
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding
8th Dec 202210:36 amRNSDirectorate Change
7th Dec 20221:33 pmRNSDirector/PDMR Shareholding
6th Dec 202211:47 amRNSTotal Voting Rights
21st Nov 20221:12 pmRNSDividend Declaration
17th Nov 20227:00 amRNSFinal Results
14th Nov 20227:00 amRNSBoard Appointment
7th Nov 20222:47 pmRNSDirector/PDMR Shareholding
11th Oct 20223:00 pmRNSDirector/PDMR Shareholding
6th Oct 20223:12 pmRNSBlock listing Interim Review
29th Sep 20223:20 pmRNSDirector/PDMR Shareholding
29th Sep 202211:08 amRNSTotal Voting Rights
20th Sep 20221:23 pmRNSDirector Declaration
12th Sep 20227:00 amRNSTRADING UPDATE
12th Sep 20227:00 amRNSTrading Update
7th Sep 20222:31 pmRNSTotal Voting Rights
6th Sep 202212:29 pmRNSDirector/PDMR Shareholding
17th Aug 20222:49 pmRNSHolding(s) in Company
8th Aug 20222:34 pmRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSCapital Markets Event
4th Jul 20223:33 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSAcquisition
14th Jun 20222:22 pmRNSAdditional Listing
8th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSHolding(s) in Company
12th May 20227:00 amRNSHalf Year Financial Results
6th May 202210:48 amRNSDirector/PDMR Shareholding
21st Apr 20222:15 pmRNSHolding(s) in Company
7th Apr 202212:01 pmRNSDirector/PDMR Shareholding
1st Apr 202212:08 pmRNSBlock listing Interim Review
25th Mar 20227:00 amRNSNotice of Interim Results
7th Mar 202212:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202212:12 pmRNSTotal Voting Rights
3rd Mar 202212:08 pmRNSHolding(s) in Company
18th Feb 202211:07 amRNSDirector/PDMR Shareholding
9th Feb 20224:00 pmRNSResult of AGM
9th Feb 20227:00 amRNSTrading Update
8th Feb 202210:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.